High-risk human papillomavirus–related oropharyngeal squamous cell carcinoma among non-indigenous and indigenous populations: a systematic review

dc.contributor.authorJu, X.
dc.contributor.authorCanfell, K.
dc.contributor.authorSmith, M.
dc.contributor.authorSethi, S.
dc.contributor.authorGarvey, G.
dc.contributor.authorHedges, J.
dc.contributor.authorLogan, R.M.
dc.contributor.authorAntonsson, A.
dc.contributor.authorJamieson, L.M.
dc.date.issued2020
dc.description.abstractOBJECTIVE:To estimate the prevalence of oral high-risk human papillomavirus (hr-HPV) infection and the proportion of hr-HPV-related oropharyngeal squamous cell carcinoma (OPSCC) among Indigenous and non-Indigenous populations. DATA SOURCE:Electronic database searches of PubMed, PubMed Central, Embase, MEDLINE, Scope, and Google Scholar were conducted for articles published from January 2000 until November 2019. REVIEW METHODS:Studies were included with a minimum of 100 cases assessing hr-HPV infection in either population samples or oropharyngeal cancer tumor series. The objective was to conduct meta-analyses to calculate the pooled prevalence of oral hr-HPV infection by adjusting for age group or sex in primary studies, the incidence of OPSCC, and the proportion of hr-HPV-related OPSCC in Indigenous people and non-Indigenous/general populations. RESULTS:We identified 47 eligible studies from 157 articles for meta-analyses. The pooled prevalence of oral hr-HPV infection was 7.494% (95% CI, 5.699%-9.289%) in a general population, with a higher prevalence among men (10.651%) than women (5.176%). The pooled incidence rate was 13.395 (95% CI, 9.315-17.475) and 7.206 (95% CI, 4.961-9.450) per 100,000 person-years in Indigenous and non-Indigenous populations, respectively. The overall pooled proportion of hr-HPV-related OPSCC was 50.812% (95 CI, 41.656%-59.969%). The highest proportion was in North America (60.221%), while the lowest proportion was in the Asia-Pacific (34.246%). CONCLUSION:Our findings suggest that in the general population, the prevalence of oral hr-HPV infection is lower among females and those in younger age groups. The incidence of OPSCC was higher among Indigenous than non-Indigenous populations, with the proportion being highest in North America.
dc.description.statementofresponsibilityXiangqun Ju, Karen Canfell, Megan Smith, Sneha Sethi, Gail Garvey, Joanne Hedges ... et al.
dc.identifier.citationOtolaryngology - Head and Neck Surgery, 2020; 165(1):23-32
dc.identifier.doi10.1177/0194599820975042
dc.identifier.issn0194-5998
dc.identifier.issn1097-6817
dc.identifier.orcidJu, X. [0000-0003-4759-3918]
dc.identifier.orcidSethi, S. [0000-0002-3571-5298]
dc.identifier.orcidHedges, J. [0000-0002-2413-5992]
dc.identifier.orcidLogan, R.M. [0000-0002-9331-1814]
dc.identifier.orcidJamieson, L.M. [0000-0001-9839-9280]
dc.identifier.urihttp://hdl.handle.net/2440/131465
dc.language.isoen
dc.publisherSAGE Publications
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1120215
dc.rightsCopyright status unknown
dc.source.urihttps://doi.org/10.1177/0194599820975042
dc.subjectIndigenous
dc.subjecthigh-risk human papillomavirus (hr-HPV)
dc.subjectmeta-analyses
dc.subjectoropharyngeal squamous cell carcinoma (OPSCC)
dc.titleHigh-risk human papillomavirus–related oropharyngeal squamous cell carcinoma among non-indigenous and indigenous populations: a systematic review
dc.typeJournal article
pubs.publication-statusPublished

Files